Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 35Myelodysplastic Syndromes 7Leukemia 5Mastocytosis, Systemic 4Congenital Abnormalities 4Leukemia, Mast-Cell 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasm, Residual 2Aggression 2Recurrence 1Rectal Neoplasms 1Mastocytosis 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia, Eosinophilic, Acute 1Leukemia, Biphenotypic, Acute 1Leukemia, Basophilic, Acute 1GATA2 Deficiency 1Blast Crisis 1

Interventions

Cytarabine 23Etoposide 8Daunorubicin 8Idarubicin 7Gene Expression Profiling 6Filgrastim 6tipifarnib 5Gemtuzumab 5Clofarabine 5Peripheral Blood Stem Cell Transplantation 4Mitoxantrone 4Cyclophosphamide 4Sorafenib 3Radiotherapy 3Flow Cytometry 3Busulfan 3Bortezomib 3Arsenic Trioxide 3tanespimycin 2laromustine 2fludarabine phosphate 2eltrombopag 2alvocidib 2aldesleukin 2Thiotepa 2Polymerase Chain Reaction 2Observation 2Microarray Analysis 2Melphalan 2Imatinib Mesylate 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia, Eosinophilic, Acute × midostaurin × Clear all
NCT00651261 2021-08-18

Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

Alliance for Clinical Trials in Oncology

Phase 3 Unknown
717 enrolled 14 charts
LymphoidOther hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Basophilic, Acute, Leukemia, Eosinophilic, Acute, Leukemia, Myelomonocytic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡